Publications & Documents


  • 25-November-2014

    English

    OECD Reviews of Health Care Quality: Turkey 2014 - Raising Standards

    Turkey underwent a very ambitious reform programme  in 2003, the so-called "Health Transformation Programme". Access to healthcare in Turkey has greatly increased with the attainment of Universal Health Coverage, as also demonstrated by improvement in health outcomes, most notably around maternal and child health and infectious diseases. However, despite these significant achievements, Turkey has a significant way to travel to deliver high-quality health services to its population. Governance of the health system is highly centralised and typified by directive control from the Ministry of Health, and information collected in different part of the system is not always fully exploited.

    The OECD Review of Health Care Quality in Turkey recommends a number of changes to address these shortcomings. The key recommendations are that: i) Turkey needs to develop robust systems to standardise and monitor the quality of care, encourage continuous professional development and incorporate patient views; ii) some loosening of the governance structure would be welcome, to allow regions greater flexibility to assess and respond to local health needs and to continue to provide health workers with incentives for improve quality; iii) data on health sector activity and outcomes need to be made more available and more usable for individual patients and clinicians, while greater effort is needed to increase the robustness of Turkey’s information systems at national level and harmonise performance measures to OECD and other international comparators.

  • 14-November-2014

    English, PDF, 478kb

    Value in Pharmaceutical Pricing: Canada Country Profile

    This country profile describes in details the Canadian pharmaceutical system, including decision-making processes for regulatory approval, reimbursement and pricing; assessment guidelines; institution and stakeholders involved and specific policies for new high cost drugs, when available.

    Related Documents
  • 14-November-2014

    English, PDF, 527kb

    Value in Pharmaceutical Pricing: Australia Country Profile

    This country profile describes in details the Australian pharmaceutical system, including decision-making processes for regulatory approval, reimbursement and pricing; assessment guidelines; institution and stakeholders involved and specific policies for new high cost drugs, when available.

    Related Documents
  • 12-November-2014

    English

    Health Systems Characteristics

    The OECD Survey on Health System Characteristics is intended to fill gaps in existing information on the institutional features of health systems, to provide input for analyses of health system performance.

    Related Documents
  • 11-November-2014

    English

    Enhancing Translational Research and Clinical Development in Alzheimer's Disease and Other Dementia: The Way Forward

    This workshop on 11-12 November 2014 in Lausanne, Switzerland will provide an international forum to discuss the challenges and barriers to the development of disease-modifying treatments and diagnostics for Alzheimer’s disease and other dementia.

    Related Documents
  • 5-November-2014

    English

    Redesigning how health services are delivered in Japan would better meet the needs of a super-ageing population, says OECD

    Elderly individuals with complex, chronic diseases need continuous and tailored care to maintain their health and maximise their ability to participate in society. Japan must change the way it delivers health services for older citizens by strengthening its specialist primary care and making mental health care services more widely available, according to a new OECD report.

    Related Documents
  • 30-October-2014

    English

    Key biotechnology indicators

    Statistics on biotechnology firms, biotechnology R&D (including public sector expenditures), biotech applications and patents.

  • 28-October-2014

    English

    OECD Science, Technology and Industry Working Papers

    The Directorate for Science, Technology and Innovation (STI) leads OECD research on the contribution of science, technology and industry to well-being and economic growth. STI Working Papers cover a broad range of topics including definition and measurement of S&T indicators, global value chains, and research on policies to promote innovation.

    Related Documents
  • 8-October-2014

    English

    Paying for Performance in Health Care: Implications for Health System Performance and Accountability

    The detailed analysis of these 10 case studies together with the rest of the analytical text highlight the realities of P4P programs and their potential impact on the performance of health systems in a diversity of settings. This book provides critical insights into the experience to date with P4P and how this tool may be better leveraged to improve health system performance and accountability.

    Related Documents
  • 6-October-2014

    English

    Paying for Performance in Health Care - Implications for Health System Performance and Accountability

    The detailed analysis of these 10 case studies together with the rest of the analytical text highlight the realities of P4P programs and their potential impact on the performance of health systems in a diversity of settings. This book provides critical insights into the experience to date with P4P and how this tool may be better leveraged to improve health system performance and accountability.

  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 > >>